Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 5:14 pm Sale | 13G | Oric Pharmaceuticals Inc. ORIC | COLUMN GROUP II LP | 3,644,118 5.200% | -27,404 (-0.75%) | View |
| 2023-11-22 4:16 pm Sale | 13D | EFFECTOR THERAPEUTICS INC EFTR | COLUMN GROUP II LP | 0 0.000% | -4,091,734 (Position Closed) | View |
| 2023-09-15 4:05 pm Sale | 13D | EFFECTOR THERAPEUTICS INC EFTR | COLUMN GROUP II LP | 4,091,734 6.600% | -217,595 (-5.05%) | View |
| 2023-01-13 4:50 pm Purchase | 13D | RAPT Therapeutics Inc. RAPT | COLUMN GROUP II LP | 4,425,439 13.100% | 1,269,211 (+40.21%) | View |
| 2022-02-11 4:54 pm Sale | 13G | Oric Pharmaceuticals Inc. ORIC | COLUMN GROUP II LP | 3,671,522 9.300% | -1,096,659 (-23.00%) | View |
| 2021-09-20 5:18 pm Sale | 13D | RAPT Therapeutics Inc. RAPT | COLUMN GROUP II LP | 3,156,228 10.700% | -1,201,019 (-27.56%) | View |
| 2021-09-07 5:12 pm Purchase | 13D | EFFECTOR THERAPEUTICS INC EFTR | COLUMN GROUP II LP | 4,309,329 10.600% | 4,309,329 (New Position) | View |
| 2021-08-30 5:21 pm Sale | 13D | RAPT Therapeutics Inc. RAPT | COLUMN GROUP II LP | 4,357,247 14.800% | -1,295,750 (-22.92%) | View |
| 2021-02-12 6:24 pm Purchase | 13G | Oric Pharmaceuticals Inc. ORIC | COLUMN GROUP II LP | 4,768,181 13.100% | 4,768,181 (New Position) | View |
| 2021-02-12 6:12 pm Sale | 13G | Gritstone bio Inc. GRTS | COLUMN GROUP II LP | 0 0.000% | -3,102,934 (Position Closed) | View |
| 2020-11-04 4:52 pm Sale | 13G | Arcus Biosciences Inc. RCUS | COLUMN GROUP II LP | 0 0.000% | -3,540,850 (Position Closed) | View |
| 2020-10-01 4:15 pm Sale | 13D | RAPT Therapeutics Inc. RAPT | COLUMN GROUP II LP | 5,652,997 23.100% | -608,000 (-9.71%) | View |
| 2020-08-26 4:42 pm Sale | 13D | RAPT Therapeutics Inc. RAPT | COLUMN GROUP II LP | 6,260,997 25.600% | -516,154 (-7.62%) | View |
| 2020-02-14 4:05 pm Unchanged | 13D | RAPT Therapeutics Inc. RAPT | COLUMN GROUP II LP | 6,777,151 27.900% | 0 (Unchanged) | View |